In the last trading session, 1.02 million shares of the GoodRx Holdings Inc (NASDAQ:GDRX) were traded, and its beta was 1.43. Most recently the company’s share price was $7.10, and it changed around $0.09 or 1.28% from the last close, which brings the market valuation of the company to $2.80B. GDRX currently trades at a discount to its 52-week high of $9.37, offering almost -31.97% off that amount. The share price’s 52-week low was $4.14, which indicates that the current value has risen by an impressive 41.69% since then. We note from GoodRx Holdings Inc’s average daily trading volume that its 10-day average is 1.22 million shares, with the 3-month average coming to 1.71 million.
GoodRx Holdings Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.29. If we narrow it down even further, the data shows that 1 out of 19 analysts rate the stock as a Sell; another 3 rate it as Overweight. Among the rest, 12 recommended GDRX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. GoodRx Holdings Inc is expected to report earnings per share of $0.07 for the current quarter.
GoodRx Holdings Inc (NASDAQ:GDRX) trade information
Instantly GDRX has showed a green trend with a performance of 1.28% at the end of last trading. The performance over the last five days has remained in the green territory. The company’s shares are currently up 5.97% year-to-date, but still up 5.19% over the last five days. On the other hand, GoodRx Holdings Inc (NASDAQ:GDRX) is 9.74% up in the 30-day period. We can see from the shorts that 9.85 million shares have been sold at a short interest cover period of 5 day(s).
The consensus price target as assigned by Wall Street analysts is $17.5, which translates to bulls needing to increase their stock price by 59.43% from its current value. Analyst projections state that GDRX is forecast to be at a low of $3 and a high of $45.
GoodRx Holdings Inc (GDRX) estimates and forecasts
GoodRx Holdings Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have risen 30.04 percent over the past six months and at a 42.86% annual growth rate that is well above the industry average of 14.00%. The year-over-year growth rate is expected to be 6.70%, up from the previous year.
Consensus estimates provided by 16 financial analysts predict the company will bring in an average of $196.01 million in revenue for the current quarter. 16 analysts expect GoodRx Holdings Inc to make $199.57 million in revenue for the quarter ending Jun 2024. The company’s sales for the same quarters a year ago were $183.99 million and $189.68 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 6.50%. Forecasts for the next quarter put sales growth at 5.20%.
GoodRx Holdings Inc earnings are expected to increase by 31.14% in 2024, but the outlook is positive 21.20% per year for the next five years.
GDRX Dividends
GoodRx Holdings Inc’s next quarterly earnings report is expected to be released around May 08 and May 13.
GoodRx Holdings Inc (NASDAQ:GDRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 11.89% of GoodRx Holdings Inc shares, and 61.60% of them are in the hands of institutional investors. The stock currently has a share float of 69.92%. GoodRx Holdings Inc stock is held by 186 institutions, with Vanguard Group Inc being the largest institutional investor. By Jun 29, 2023, it held 10.11% of the shares, which is about 8.5 million shares worth $46.94 million.
Silver Lake Group, LLC, with 4.20% or 3.53 million shares worth $19.5 million as of Jun 29, 2023, holds the second largest percentage of outstanding shares.
Vanguard Total Stock Market Index Fund and Vanguard Small-Cap Index Fund were the top two Mutual Funds as of Jun 29, 2023. The former held 2.33 million shares worth $12.88 million, making up 2.77% of all outstanding shares. On the other hand, Vanguard Small-Cap Index Fund held roughly 1.82 million shares worth around $10.07 million, which represents about 2.17% of the total shares outstanding.
